文献速递角膜与眼表疾病

上皮去除角膜胶原交联治疗角膜扩张的安全性与有效性:美国眼科学会报告

Safety and Efficacy of Epithelium-Off Corneal Collagen Cross-Linking for the Treatment of Corneal Ectasia: A Report by the American Academy of Ophthalmology.
PubMed 文献 · Ophthalmology · 2024-06-26

美国眼科学会系统综述了上皮去除角膜胶原交联(CXL)治疗进展性角膜扩张的证据,纳入6项前瞻性随机对照试验(5项圆锥角膜、1项激光屈光术后角膜扩张),平均随访2.4年。所有研究显示治疗组进展率低于对照组,最大角膜曲率值、矫正远视力及未矫正远视力改善,CXL组角膜厚度下降更明显,并发症罕见。结论认为上皮去除CXL对多数患者有效减少进展且安全性可接受。

要点

  • 上皮去除CXL在多数圆锥角膜和激光屈光术后角膜扩张患者中减少进展。
  • 治疗组最大角膜曲率值、矫正远视力及未矫正远视力较对照组改善。
  • 两组角膜厚度均下降,但CXL组下降更明显,并发症罕见。

核心结论

  • 上皮去除CXL对多数圆锥角膜和激光屈光术后角膜扩张患者有效减少进展,安全性可接受。

研究设计与样本

  • 美国眼科学会通过PubMed数据库检索(最近一次2024年3月,无日期限制,限英文),初检359篇文献,43篇全文审阅,最终6篇纳入。
  • 纳入6项前瞻性随机对照试验,5项评估圆锥角膜、1项评估激光屈光术后角膜扩张,平均术后随访2.4年(范围1-5年)。
  • 方法学家评定5项为I级证据、1项为II级证据,无III级研究。

主要发现

  • 所有研究显示治疗组进展率低于对照组。
  • 治疗组最大角膜曲率值、矫正远视力及未矫正远视力较对照组改善。
  • 两组角膜厚度均下降,但CXL组下降更明显。
  • 并发症罕见。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To review the evidence on the safety and effectiveness of epithelium-off corneal collagen cross-linking (CXL) for the treatment of progressive corneal ectasia. METHODS: A literature search of the PubMed database was most recently conducted in March 2024 with no date restrictions and limited to studies published in English. The search identified 359 citations that were reviewed in abstract form, and 43 of these were reviewed in full text. High-quality randomized clinical trials comparing epithelium-off CXL with conservative treatment in patients who have keratoconus (KCN) and post-refractive surgery ectasia were included. The panel deemed 6 articles to be of sufficient relevance for inclusion, and these were assessed for quality by the panel methodologist; 5 were rated level I, and 1 was rated level II. There were no level III studies. RESULTS: This analysis includes 6 prospective, randomized controlled trials that evaluated the use of epithelium-off CXL to treat progressive KCN (5 studies) and post-laser refractive surgery ectasia (1 study), with a mean postoperative follow-up of 2.4 years (range, 1-5 years). All studies showed a decreased progression rate in treated patients compared with controls. Improvement in the maximum keratometry (Kmax) value, corrected distance visual acuity (CDVA), and uncorrected distance visual acuity (UDVA) was observed in the treatment groups compared with control groups. A decrease in corneal thickness was observed in both groups but was greater in the CXL group. Complications were rare. CONCLUSIONS: Epithelium-off CXL is effective in reducing the progression of KCN and post-laser refractive surgery ectasia in most treated patients with an acceptable safety profile. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Cortina MS, Greiner MA, Kuo AN, et al. Safety and Efficacy of Epithelium-Off Corneal Collagen Cross-Linking for the Treatment of Corneal Ectasia: A Report by the American Academy of Ophthalmology. Ophthalmology. 2024. PMID: 38935041. doi:10.1016/j.ophtha.2024.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。